Trials / Unknown
UnknownNCT03672149
Safety and Therapeutic Drug Monitoring of Cefazolin in Continuous Renal Replacement Therapy
A Prospective, Open-Label Study of the Safety and Therapeutic Drug Monitoring of Continuous Infusion Cefazolin Through the Addition of the Cefazolin Into the Continuous Renal Replacement Therapy Solution.
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Drexel University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This investigation is intended to collect safety information for the technique of mixing cefazolin in the CRRT solution on the CRRT circuit, the patient, in addition to collecting information regarding the ability to obtain therapeutic cefazolin serum concentrations
Detailed description
This investigation is intended to collect safety information for the technique of mixing cefazolin in the CRRT solution on the CRRT circuit, the patient, in addition to collecting information regarding the ability to obtain therapeutic cefazolin serum concentrations in addition to utilizing a dosing algorithm to adjust the cefazolin concentration in the CRRT solution.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cefazolin | Mixing cefazolin into the CRRT solution(s) for delivery as a continuous infusion |
Timeline
- Start date
- 2019-07-18
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2018-09-14
- Last updated
- 2020-10-19
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03672149. Inclusion in this directory is not an endorsement.